Abstract
Tumors infiltrating the esophago-gastric junction (EGJ) are characterized by a worse prognosis than cancers of the middle and lower thirds of the stomach. The definition, classification, and treatment of these tumors have yet to be definitively standardized. Complete resection of the tumor is considered the main goal of surgery, although the best approach and the appropriate extent of surgical resection continue to be debated. This chapter discusses the extent of gastric and esophageal resection as well as that of lymph node dissection. Long-term results and the main factors affecting prognosis are presented. The limits of primary surgery are defined and the adoption of pre-operative multimodality treatments in the context of controlled clinical trials encouraged.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wu H, Rusiecki JA, Zhu K et al (2009) Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev 18:1945–1952
Marrelli D, Pedrazzani C, Morgagni P et al on behalf of the Italian Research Group for Gastric Cancer (2011) Changing clinical and pathological features of gastric cancer in the period 1991–2005. A statistical evaluation of the Italian research group for gastric cancer (IRGCC) database. Br J Surg. Epub ahead of print
American Joint Committee on Cancer (2006) AJCC Cancer Staging Atlas. Springer Science+Business Media, New York
Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric-junction. Br J Surg 85:1457–1459
Siewert JR, Feith M, Werner M et al (2000) Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 232:353–361
de Manzoni G, Pedrazzani C, Pasini F et al (2002) Results of surgical treatment of adenocarcinoma of the gastric cardia. Ann Thorac Surg 73:1035–1040
Pedrazzani C, de Manzoni G, Marrelli D et al (2007) It is time for a proper staging system for adenocarcinoma of the gastro-esopageal junction. J Clin Oncol 25:907–908
Marsman WA, Tytgat GNJ, ten Kate FJW et al (2005) Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction. J Surg Oncol 92:160–168
McColl KEL, Going JJ (2010) Aetiology and classification of adenocarcinoma of the gastro-esophageal junction/cardia. Gut 59:282–284
American Joint Committee on Cancer (2010) AJCC Cancer Staging Manual, 7th edn. Springer Science+Business Media, New York
Lagarde SM, ten Kate FJW, Reitsma JB et al (2006) Prognostic Factors in Adenocarcinoma of the Esophagus or Gastroesophageal Junction. J Clin Oncol 24:4347–4355
Rice TW, Zuccaro G, Adelstein DJ (1998) Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 65:787–792
Ito H, Clancy TE, Osteen RT et al (2004) Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg 199:880–886
Pedrazzani C, de Manzoni G, Marrelli D et al (2007) Nodal staging in adenocarcinoma of the gastro-esophageal junction. Proposal of a specific staging system. Ann Surg Oncol 14:299–305
Sasako M, Sano T, Yamamoto S et al for the Japan Clinical Oncology Group (2006) Left thoracoabdominal approach versus abdominal transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 7:644–651
Barbour AP, Rizk NP, Gonen M et al (2007) Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 246:1–6
Kurokawa Y, Sasako M, Sano T et al for the Japan Clinical Oncology Group (2011) Randomized controlled trials comparing postoperative changes in body weight, symptoms and respiratory function after estende surgery in gastric cancer patients. Br J Surg in press
Dresner SM, Lamb PJ, Bennett MK et al (2001) The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 129:103–109
Pedrazzani C, de Manzoni G, Marrelli D et al (2007) Lymph node involvement in advanced gastro-esophageal junction adenocarcinoma. J Thorac Cardiovasc Surg 134:378–385
Peters CJ, Hardwick RH, Vowler SL et al for the Oesophageal Cancer Clinical and Molecular Stratification Study Group (2009) Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma. Br J Surg 96:724–733
Nigro JJ, DeMeester SR, Hagen JA et al (1999) Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 117:960–968
Yuasa N, Miyake H, Yamada T et al (2006) Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction. World J Surg 30:364–371
Wijnhoven BPL, Siersema PD, Hop WCJ et al (1999) Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Br J Surg 86:529–535
Roviello F, Pedrazzani C, Marrelli D et al (2010) Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol 36:439–446
Hsu CP, Wu CC, Chen CY et al (1997) Clinical experience in radical lymphadenectomy for adenocarcinoma of the gastric cardia. J Thorac Cardiovasc Surg 114:544–551
Kitamura K, Nishida S, Yamamoto K et al (1998) Lymph node metastasis in gastric cancer in the upper third of the stomach. Surgical treatment an the basis of the anatomical distribution of positive node. Hepatogastroenterology 45:281–285
Maeta M, Yamashiro H, Saito H et al (1999) A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy. Surgery 125:325–331
Wu CW, Hsiung CA, Lo SS et al (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7:309–315
Songun I, Putter H, Kranenbarg EM et al (2010). Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11:404–405
Sasako M, Sano T, Yamamoto S et al (2008) Japan Clinical Oncology Group. D2 lymphadenectomy alone or with paraaortic nodal dissection for gastric cancer. New Engl J Med 359:453–462
Di Leo A, Marrelli D, Roviello F et al (2007). Lymph node involvement in gastric cancer for different tumor’s site and T stage. Italian Research Group for Gastric Cancer (IRGGC) experience. J Gastrointest Surg 11:1146–1153
Mariette C, Castel B, Baton JM et al (2003) Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur J Surg Oncol 29:588–593
Siewert JR, Bottcher K, Stein HJ (1995) Problem of proximal third gastric carcinoma. World J Surg 19:523–531
Collard JM (2001) Exclusive radical surgery for esophageal adenocarcinoma. Cancer 91:1098–1104
Mariette C, Castel B, Toursel H et al (2002) Surgical management of and long-term survival after adenocarcinoma of the cardia. Br J Surg 89:1156–1163
de Manzoni, Pedrazzani C, Pasini F et al (2003) Pattern of recurrence after surgery in adenocarcinoma of the gastrooesophageal junction. Eur J Surg Oncol 29:506–510
Lerut T, Coosemans W, Decker G et al (2004) Extended surgery for cancer of the esophagus and gastroesophageal junction. J Surg Res 117:58–63
Wayman J, Bennett MK, Raimes SA et al (2002) The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction. Br J Cancer 86:1223–1229
Barbour AP, Rizk NP, Gonen M et al (2007) Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol 14:306–316
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
de Manzoni, G., Zanoni, A., Pedrazzani, C. (2012). Surgical Treatment of Gastric Cancer Infiltrating the Esophago-gastric Junction. In: de Manzoni, G., Roviello, F., Siquini, W. (eds) Surgery in the Multimodal Management of Gastric Cancer. Springer, Milano. https://doi.org/10.1007/978-88-470-2318-5_18
Download citation
DOI: https://doi.org/10.1007/978-88-470-2318-5_18
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2317-8
Online ISBN: 978-88-470-2318-5
eBook Packages: MedicineMedicine (R0)